相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017
Ryan K. McBain et al.
ANNALS OF INTERNAL MEDICINE (2020)
DATA 2000 waiver training for medical students: Lessons learned from a medical school experience
Erin Zerbo et al.
SUBSTANCE ABUSE (2020)
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities
Adam J. Gordon et al.
SUBSTANCE ABUSE (2020)
Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US
Alexandra Duncan et al.
JAMA NETWORK OPEN (2020)
Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care
Evelyn T. Chang et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Geographic location of buprenorphine-waivered physicians and integration with health systems
Brendan Saloner et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2020)
Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic
Jocelyn R. James et al.
SUBSTANCE ABUSE (2019)
Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions
Joanne Spetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Underutilization of medications to treat opioid use disorder: What role does stigma play?
Bennett Allen et al.
SUBSTANCE ABUSE (2019)
Patients With Opioid Use Disorder Deserve Trained Providers
Melissa B. Weimer et al.
ANNALS OF INTERNAL MEDICINE (2019)
Trends In Buprenorphine Prescribing By Physician Specialty
Hefei Wen et al.
HEALTH AFFAIRS (2019)
Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder X the X Waiver
Kevin Fiscella et al.
JAMA PSYCHIATRY (2019)
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
Rebecca L. Haffajee et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)
Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps
Jessica J. Wyse et al.
SUBSTANCE ABUSE (2018)
Developing an opioid use disorder treatment cascade: A review of quality measures
Arthur Robin Williams et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
The Role of Science in Addressing the Opioid Crisis
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Surgeon General's Facing Addiction report: An historic document for health care
Sharon Levy et al.
SUBSTANCE ABUSE (2017)
Why aren't physicians prescribing more buprenorphine?
Andrew S. Huhn et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2017)
Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment
Bradley D. Stein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
Christopher M. Jones et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2015)
Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11
Andrew W. Dick et al.
HEALTH AFFAIRS (2015)
Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence A Randomized Clinical Trial
Gail D'Onofrio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties
Bradley D. Stein et al.
MILBANK QUARTERLY (2015)
Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers
Matthew Tierney et al.
SUBSTANCE ABUSE (2015)
Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies
Xiaofan Li et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Medication-Assisted Therapies - Tackling the Opioid-Overdose Epidemic
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Cindy Parks Thomas et al.
PSYCHIATRIC SERVICES (2014)
Trends in Opioid Agonist Therapy in the Veterans Health Administration: Is Supply Keeping up with Demand?
Elizabeth M. Oliva et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2013)
Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them
Elizabeth M. Oliva et al.
CURRENT PSYCHIATRY REPORTS (2011)
Improved Quality of Life, Clinical, and Psychosocial Outcomes Among Heroin-dependent Patients on Ambulatory Buprenorphine Maintenance
Alexander M. Ponizovsky et al.
SUBSTANCE USE & MISUSE (2010)
Outcomes of DATA 2000 Certification Trainings for the Provision of Buprenorphine Treatment in the Veterans Health Administration
Adam J. Gordon et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians
Chinazo O. Cunningham et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Quality of life among heroin users on buprenorphine versus methadone maintenance
Alexander M. Ponizovsky et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2007)
Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment
Salvatore M. Giacomuzzi et al.
THESCIENTIFICWORLDJOURNAL (2005)
From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States
JH Jaffe et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Buprenorphine versus methadone maintenance treatment in an ambulant setting:: a health-related quality of life assessment
SM Giacomuzzi et al.
ADDICTION (2003)
分享论文
